Are you passionate about ATA and its mission? If so, consider applying to serve on…
Keeping an Eye Out for Thyroid Eye Disease Matthew Ettleson, MD University of Chicago Medicine…
New Rochelle, NY, March 17, 2021—New guidelines for the diagnosis, evaluation, and treatment of anaplastic…
Expanding Medical Therapies for Medullary Thyroid Cancer Sarika Rao, DO, FACE Mayo Clinic, FL February…
Many patients have questions about receiving the COVID-19 vaccine. ATA's Public Health Committee has developed…
An Approach to the Patient with Thyroid Disease and High Symptom Burden Benjamin Gigliotti, MD…
Don't miss out on the opportunity to nominate a colleague or mentor for one of…
Are you interested in serving as the Editor-in-Chief of the world’s leading journal for thyroid-related research?…
Is Prescription Levothyroxine Really an Artificial Hormone? Rupendra T. Shrestha, MD University of Minnesota, Minneapolis,…
The inaugural ATA's Year in Thyroidology: A Virtual Experience will be on February 19-20, 2021. …
Hyperthyroidism Awareness: Understanding the diagnosis and all treatment options Sarah Oltmann, MD University of Texas…
Jochen Lorch Harvard Medical School, Boston, MA October 16, 2020 Anaplastic or undifferentiated thyroid…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.